Dysregulation of Immune Cell Regulatory Pathways by Mtb in the Context of HIV Infection (R61/R33)

Archived

National Institutes of Health

Description

The purpose of this funding opportunity announcement (FOA) is to invite applications to support innovative preclinical research to identify Mycobacterium tuberculosis (Mtb)-mediated changes in key immune cell regulatory pathways in the context of HIV infection and evaluate strategies to reverse these changes to treat TB and TB/HIV infection, limit long-term disease associated tissue damage, and/or potentiate vaccine effectiveness.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedApr 7, 2017
  • ClosesAug 1, 2017
  • CFDA93.855, 93.856
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro